The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma
Clinical trial NCT03407495 · COMPLETED
Trial details
- NCT number
- NCT03407495
- Sponsor
- MegaPro Biomedical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-22
- Primary completion
- 2020-08-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.